肺癌组织中MTA1、VEGF-C表达水平与患者临床分期及预后的相关性<sup>*</sup>

doi:10.3969/j.issn.1671-7171.2024.07.004

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1240 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨肺癌组织中转移相关基因1(MTA1)、血管内皮生长因子 C(VEGF-C)表达水平及其与患者临床分期及预后的相关性。【方法】回顾分析本院收治的85例肺癌患者的临床资料,收集患者的肺癌组织及癌旁组织,采用免疫组化法检测MTA1、VEGF-C阳性表达情况,采用PCR荧光定量法检测MTA1、VEGF-C表达水平,比较不同临床病理参数、预后结局患者的MTA1、VEGF-C阳性表达率。【结果】肺癌组织MTA1、VEGF-C阳性表达率及两者表达水平均高于癌旁组织,差异有统计学意义(P<0.05)。不同TNM分期、肿瘤直径及分化、淋巴结转移、脉管侵犯、预后情况患者的MTA1、VEGF-C阳性表达率及表达水平比较,差异均有统计学意义(P<0.05)。MTA1及VEGF-C阳性表达患者24个月累积无进展生存率分别低于两者阴性表达患者,差异有统计学意义(P<0.05)。肺癌组织中MTA1、VEGF-C表达水平与肿瘤TNM分期、肿瘤直径、淋巴结转移、脉管侵犯、预后结局均呈正相关(P<0.05),与分化程度呈负相关(P<0.05)。【结论】MTA1、VEGF-C在肺癌组织内多呈阳性表达,其表达水平与肿瘤病理分期、肿瘤直径、预后等密切相关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：肺肿瘤/病理学, 血管内皮生长因子C, 肿瘤分期, 预后

Abstract：【Objective】To analyze the expression levels of metastasis related gene 1 (MTA1) and vascular endothelial growth factor C (VEGF-C) in lung cancer tissue and their correlation with clinical staging and prognosis of patients.【Methods】Retrospective analysis of clinical data from 85 patients diagnosed with lung cancer in our hospital. All lung cancer tissues and adjacent tissues of the patients were collected as pathological specimens, and the positive expression rates of MTA1 and VEGF-C were detected using immunohistochemistry. Meanwhile, the expression levels of MTA1 and VEGF-C was detected by PCR fluorescence quantification method. The positive expression rates of MTA1 and VEGF-C were compared among patients with different clinical pathological parameters and prognostic outcomes. 【Results】The positive rates of MTA1 and VEGF-C in lung cancer tissues were higher than those in adjacent tissues (P<0.05). And the expression levels of both proteins of cancer tissues were also higher than those of the adjacent tissues (P<0.05). The positive rates and expression levels of MTA1 and VEGF-C in patients with TNM stages, low differentiation, tumor diameter>5 cm, lymph node metastasis, vascular invasion, and poor prognosis showed an upward trend (P<0.05). The cumulative progression free survival rate at 24 months in the MTA1 positive expression group was lower than the negative expression group (P<0.05). The survival rate of the VEGF-C positive expression group was lower than the negative expression group, and the difference was significant (P<0.05). The expression of MTA1 and VEGF-C in lung cancer tissue is closely related to tumor TNM staging, differentiation degree, tumor diameter, lymph node metastasis, vascular invasion, and prognosis (P<0.05). 【Conclusion】MTA1 and VEGF-C are often positively expressed in lung cancer tissues, and their expression levels can serve as important factors for evaluating pathological features such as tumor staging, diameter, and prognosis to a certain extent. It is worth further exploration in clinical practice.

Key words： Lung Neoplasms/PA Vascular Endothelial Growth Factor C Neoplasm Staging Prognosis

收稿日期: 2024-02-21

中图分类号:

R734.2

基金资助:* 湖南省卫生健康委员会一般指导项目(D202303107662)

通讯作者: ** E-mail:597148639@qq.com

引用本文:

彭雅亚, 刘克勤, 李筝, 李新宇, 汪砥. 肺癌组织中MTA1、VEGF-C表达水平与患者临床分期及预后的相关性^*[J]. 医学临床研究, 2024, 41(7): 973-976.
PENG Yaya, LIU Keqin, LI Zheng, et al. Expression of MTA1 and VEGF-C in Lung Cancer Tissue and Correlation with Clinical Staging and Prognosis of Patients. JOURNAL OF CLINICAL RESEARCH, 2024, 41(7): 973-976.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.07.004 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I7/973

[1] CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J].Chin Med J (Engl),2021,134(7):783-791.
[2] 张杰,刘永昌,刘浩. 细胞角蛋白19片段21-1、转移相关基因1、切除修复交叉互补基因1在肺癌中的应用价值[J].实用医院临床杂志,2023,20(5):115-118.
[3] 孙芳洲,王劲松,李春晓,等. 肿瘤转移相关基因1对宫颈癌HeLa细胞放疗敏感性的作用及机制[J].中华肿瘤杂志,2022,44(9):962-967.
[4] 李敏,朱家胜. HER-2与VEGF-C在胃癌组织中的表达及其相关性研究[J].浙江临床医学,2019,21(8):1042-1044.
[5] 徐然,胡子馨,彭莎,等. 穴位埋线对肺癌患者化疗相关恶心、呕吐的影响[J].医学临床研究,2023,40(5):648-651.
[6] 李雅,丁海斌,陈静,等. 血清Wnt通路抑制因子Dickkopf-1、血管内皮生长因子A和生长分化因子15对早期肺癌的诊断价值研究[J].陕西医学杂志,2023,52(9):1225-1227.
[7] 王华寿,卢陈嘉,黄俊文,等. 肺癌组织环指蛋白181、转移相关基因1、血管内皮生长因子C表达及与患者临床病理特征和预后相关性分析[J].陕西医学杂志,2023,52(1):110-113.
[8] MA K, LI Y X, GUO Q Q. Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer[J].Neoplasma,2022,69(5):1092-1100.
[9] 王丽,郭宏艳,何利珍,等. 结肠癌转移相关基因1、分离酶抑制蛋白在乳腺癌进展中的作用[J].实用医院临床杂志,2022,19(2):1-5.
[10] LIU J, LI C X, XUE H S, LI L, et al. Cancer metastasis-associated protein 1 localizes to the nucleolus and regulates pre-rRNA synthesis in cancer cells[J].J Cell Biochem,2021,122(2):180.
[11] JONAS F, KESA P, PARAL P, et al. The effect of vascular endothelial growth factor C and adipose-derived stem cells on lymphatic regeneration in a rat vascularized lymph node transfer model[J].J Reconstr Microsurg,2023,39(4):311-319.
[12] 许高云,夏步胜,蒋业忠. 子宫内膜癌组织中血管内皮生长因子-C、细胞增殖抗原Ki-67的表达及意义[J].中国临床医生杂志,2022,50(4):481-484.
[13] HLOPHE Y N, JOUBERT A M. Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion[J].J Cell Mol Med,2022,26(23):5743-5754.
[14] VIMALRAJ S, HARIPRABU K N G, RAHAMAN M, et al. Vascular endothelial growth factor-C and its receptor-3 signaling in tumorigenesis[J].3 Biotech,2023,13(10):326.